These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36332653)

  • 1. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
    Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
    Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
    Macleod D; Shanaube K; Skalland T; Limbada M; Mandla N; Bwalya J; Schaap A; Yang B; Donnell D; Piwowar-Manning E; Eshleman SH; Hoddinott G; Bond V; Moore A; Griffith S; Bock P; Ayles H; Fidler S; Hayes R; Floyd S;
    Lancet HIV; 2022 Nov; 9(11):e751-e759. PubMed ID: 36332652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities.
    Mulubwa C; Hensen B; Phiri MM; Shanaube K; Schaap AJ; Floyd S; Phiri CR; Bwalya C; Bond V; Simwinga M; Mwenge L; Fidler S; Hayes R; Mwinga A; Ayles H;
    Lancet HIV; 2019 Feb; 6(2):e81-e92. PubMed ID: 30584047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study.
    Probert WJM; Sauter R; Pickles M; Cori A; Bell-Mandla NF; Bwalya J; Abeler-Dörner L; Bock P; Donnell DJ; Floyd S; Macleod D; Piwowar-Manning E; Skalland T; Shanaube K; Wilson E; Yang B; Ayles H; Fidler S; Hayes RJ; Fraser C;
    Lancet HIV; 2022 Nov; 9(11):e771-e780. PubMed ID: 36332654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    Telisinghe L; Floyd S; MacLeod D; Schaap A; Dunbar R; Bwalya J; Bell-Mandla N; Piwowar-Manning E; Donnell D; Shaunaube K; Bock P; Fidler S; Hayes RJ; Ayles HM;
    PLoS Med; 2024 May; 21(5):e1004393. PubMed ID: 38820246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
    N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.
    Hayes R; Ayles H; Beyers N; Sabapathy K; Floyd S; Shanaube K; Bock P; Griffith S; Moore A; Watson-Jones D; Fraser C; Vermund SH; Fidler S;
    Trials; 2014 Feb; 15():57. PubMed ID: 24524229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial.
    Limbada M; Macleod D; Situmbeko V; Muhau E; Shibwela O; Chiti B; Floyd S; Schaap AJ; Hayes R; Fidler S; Ayles H;
    Lancet HIV; 2022 Jan; 9(1):e13-e23. PubMed ID: 34843674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa.
    Bond V; Hoddinott G; Viljoen L; Ngwenya F; Simuyaba M; Chiti B; Ndubani R; Makola N; Donnell D; Schaap A; Floyd S; Hargreaves J; Shanaube K; Fidler S; Bock P; Ayles H; Hayes R; Simwinga M; Seeley J;
    Trials; 2021 Apr; 22(1):251. PubMed ID: 33823907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.
    Hargreaves JR; Stangl A; Bond V; Hoddinott G; Krishnaratne S; Mathema H; Moyo M; Viljoen L; Brady L; Sievwright K; Horn L; Sabapathy K; Ayles H; Beyers N; Bock P; Fidler S; Griffith S; Seeley J; Hayes R;
    Health Policy Plan; 2016 Dec; 31(10):1342-1354. PubMed ID: 27375126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
    PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART).
    Skalland T; Ayles H; Bock P; Bwalya J; Shanaube K; Kasese N; Dupré M; Kosloff B; Floyd S; Wilson E; Moore A; Eshleman S; Fidler S; Hayes R; Donnell D;
    J Int AIDS Soc; 2023 Aug; 26(8):e26155. PubMed ID: 37643290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case-control study.
    Sabapathy K; Mubekapi-Musadaidzwa C; Mulubwa C; Schaap A; Hoddinott G; Stangl A; Floyd S; Ayles H; Fidler S; Hayes R;
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29251433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.